Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $487K | $1.55M | $3.43M | $1.02M | $1.86M | $1.43M | $1.32M | $1.52M |
| Revenue growth | — | — | 217.5% | 122.1% | -70.4% | 82.6% | -22.9% | -7.6% | 15.2% |
| Gross profit | — | $45.6K | $89.3K | $2.68M | $720K | $1.19M | $937K | $759K | $838K |
| Gross margin | — | 9.4% | 5.8% | 77.9% | 70.8% | 64.1% | 65.4% | 57.4% | 55.0% |
| Operating income | — | -$234K | -$315K | -$158K | -$1.86M | -$1.53M | -$2.15M | -$2.57M | -$3.26M |
| Operating margin | — | -48.1% | -20.3% | -4.6% | -182.8% | -82.6% | -150.0% | -194.5% | -213.7% |
| Net income | -$75.4K | -$130K | -$716K | $355K | -$2.52M | -$1.69M | -$2.10M | -$2.47M | -$2.28M |
| Net margin | — | -26.8% | -46.3% | 10.3% | -248.2% | -90.9% | -146.9% | -186.8% | -149.6% |
| EPS (diluted) | $0.00 | $0.00 | $0.00 | $0.00 | -$0.01 | -$0.02 | -$0.55 | -$31.74 | -$2.85 |
| Fiscal year | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$100K | -$348K | -$704K | -$558K | -$846K | -$812K | -$2.00M | -$2.73M | -$2.41M |
| Capital expenditures | — | — | — | $4.73K | $3.96K | — | — | — | — |
| Free cash flow | — | — | — | -$563K | -$850K | — | — | — | — |
| Fiscal year | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $2.31M | $3.45M | $2.74M | $3.52M | $2.60M | $1.44M | $4.83M | $2.04M | $140K |
| Total assets | $2.31M | $5.20M | $4.34M | $7.21M | $4.72M | $2.79M | $5.74M | $3.24M | $24.6M |
| Total liabilities | $8.10K | $242K | $84.0K | $1.29M | $1.41M | $1.23M | $1.36M | $1.31M | $2.17M |
| Shareholders' equity | $2.30M | $4.96M | $4.25M | $5.92M | $3.31M | $1.54M | $4.37M | $1.93M | $22.5M |
| Retained earnings | -$100K | -$373K | -$1.09M | -$734K | -$3.26M | -$4.95M | -$7.05M | -$9.52M | -$11.8M |
| Shares (wtd avg diluted) | 371M | 376M | 376M | 376M | 376M | 87.8M | 3.79M | 77.8B | 801K |
Every figure is extracted from Agape ATP Corp’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.